25 XP   0   0   10

Novolog Pharm-Up 1966 Ltd
Buy, Hold or Sell?

Let's analyse Novolog together

PenkeI guess you are interested in Novolog Pharm-Up 1966 Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Novolog Pharm-Up 1966 Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Novolog Pharm-Up 1966 Ltd

I send you an email if I find something interesting about Novolog Pharm-Up 1966 Ltd.

Quick analysis of Novolog (30 sec.)










What can you expect buying and holding a share of Novolog? (30 sec.)

How much money do you get?

How much money do you get?
ILA0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
ILA77.56
Expected worth in 1 year
ILA25.93
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
ILA-38.40
Return On Investment
-24.5%

For what price can you sell your share?

Current Price per Share
ILA156.90
Expected price per share
ILA140.77 - ILA167.16
How sure are you?
50%

1. Valuation of Novolog (5 min.)




Live pricePrice per Share (EOD)

ILA156.90

Intrinsic Value Per Share

ILA296.61 - ILA417.88

Total Value Per Share

ILA374.17 - ILA495.44

2. Growth of Novolog (5 min.)




Is Novolog growing?

Current yearPrevious yearGrowGrow %
How rich?$106.9m$124.7m-$17.7m-16.6%

How much money is Novolog making?

Current yearPrevious yearGrowGrow %
Making money-$11.3m$12.9m-$24.2m-213.8%
Net Profit Margin-2.6%3.2%--

How much money comes from the company's main activities?

3. Financial Health of Novolog (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

What can you expect buying and holding a share of Novolog? (5 min.)

Welcome investor! Novolog's management wants to use your money to grow the business. In return you get a share of Novolog.

What can you expect buying and holding a share of Novolog?

First you should know what it really means to hold a share of Novolog. And how you can make/lose money.

Speculation

The Price per Share of Novolog is ILA156.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Novolog.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Novolog, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ILA77.56. Based on the TTM, the Book Value Change Per Share is ILA-12.91 per quarter. Based on the YOY, the Book Value Change Per Share is ILA6.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ILA3.31 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Novolog.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per ShareILA% of Price per Share
Usd Eps-0.020.0%-0.020.0%0.030.0%0.010.0%0.010.0%
Usd Book Value Change Per Share-0.030.0%-0.030.0%0.020.0%0.030.0%0.020.0%
Usd Dividend Per Share0.010.0%0.010.0%0.020.0%0.010.0%0.010.0%
Usd Total Gains Per Share-0.030.0%-0.030.0%0.030.0%0.040.0%0.030.0%
Usd Price Per Share0.38-0.38-0.75-0.64-0.40-
Price to Earnings Ratio-17.28--17.28-29.59-34.47-23.36-
Price-to-Total Gains Ratio-14.80--14.80-22.20-11.42-15.36-
Price to Book Ratio1.83-1.83-3.06-3.40-3.23-
Price-to-Total Gains Ratio-14.80--14.80-22.20-11.42-15.36-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.4234731
Number of shares2361
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share-0.030.03
Usd Total Gains Per Share-0.030.04
Gains per Quarter (2361 shares)-61.17100.52
Gains per Year (2361 shares)-244.68402.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
184-329-255108294392
2169-658-500216588794
3253-987-7453248821196
4337-1316-99043211761598
5422-1645-123554014702000
6506-1974-148064917642402
7590-2303-172575720582804
8675-2632-197086523523206
9759-2961-221597326463608
10843-3290-2460108129404010

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%9.01.00.090.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%8.02.00.080.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%9.01.00.090.0%

Fundamentals of Novolog

About Novolog Pharm-Up 1966 Ltd

Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Health Services, and Digital. The Logistics division engages in the import and distribution of medicine and medical products; logistics of clinical trials; provision of pharmaceutical services to customers; and sterilization of perishable medical equipment. The Health Services division provides customized medical services, laboratory services, and other medical services to patients, health organizations, insurance companies, multinational companies, and government bodies. The Digital division develops technological tools for health services; deals with making medical information accessible to the public through medical websites; promotes digital presence for clinics; and operates and markets digital platforms for physicians and clinics. Novolog (Pharm-Up 1966) Ltd was incorporated in 1966 and is based in Modi'in-Maccabim-Re'ut, Israel.

Fundamental data was last updated by Penke on 2024-04-24 05:35:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Novolog Pharm-Up 1966 Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Novolog earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Novolog to the Medical Distribution industry mean.
  • A Net Profit Margin of -2.6% means that -0.03 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Novolog Pharm-Up 1966 Ltd:

  • The MRQ is -2.6%. The company is making a loss. -1
  • The TTM is -2.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-2.6%0.0%
TTM-2.6%YOY3.2%-5.7%
TTM-2.6%5Y1.7%-4.3%
5Y1.7%10Y2.5%-0.8%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.6%1.9%-4.5%
TTM-2.6%2.1%-4.7%
YOY3.2%2.5%+0.7%
5Y1.7%2.2%-0.5%
10Y2.5%2.1%+0.4%
1.1.2. Return on Assets

Shows how efficient Novolog is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Novolog to the Medical Distribution industry mean.
  • -1.5% Return on Assets means that Novolog generated -0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Novolog Pharm-Up 1966 Ltd:

  • The MRQ is -1.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.5%TTM-1.5%0.0%
TTM-1.5%YOY2.0%-3.5%
TTM-1.5%5Y0.9%-2.4%
5Y0.9%10Y1.2%-0.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.5%1.0%-2.5%
TTM-1.5%0.9%-2.4%
YOY2.0%1.2%+0.8%
5Y0.9%1.0%-0.1%
10Y1.2%1.1%+0.1%
1.1.3. Return on Equity

Shows how efficient Novolog is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Novolog to the Medical Distribution industry mean.
  • -11.3% Return on Equity means Novolog generated -0.11 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Novolog Pharm-Up 1966 Ltd:

  • The MRQ is -11.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.3%TTM-11.3%0.0%
TTM-11.3%YOY11.0%-22.3%
TTM-11.3%5Y5.4%-16.7%
5Y5.4%10Y16.9%-11.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.3%2.4%-13.7%
TTM-11.3%2.4%-13.7%
YOY11.0%2.4%+8.6%
5Y5.4%2.4%+3.0%
10Y16.9%2.9%+14.0%

1.2. Operating Efficiency of Novolog Pharm-Up 1966 Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Novolog is operating .

  • Measures how much profit Novolog makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Novolog to the Medical Distribution industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Novolog Pharm-Up 1966 Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY5.2%-5.2%
TTM-5Y4.0%-4.0%
5Y4.0%10Y4.5%-0.6%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.0%-3.0%
TTM-2.6%-2.6%
YOY5.2%3.3%+1.9%
5Y4.0%3.4%+0.6%
10Y4.5%3.1%+1.4%
1.2.2. Operating Ratio

Measures how efficient Novolog is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.87 means that the operating costs are 1.87 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Novolog Pharm-Up 1966 Ltd:

  • The MRQ is 1.866. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.866. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.866TTM1.8660.000
TTM1.866YOY1.831+0.035
TTM1.8665Y1.846+0.020
5Y1.84610Y1.851-0.004
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8661.571+0.295
TTM1.8661.413+0.453
YOY1.8311.482+0.349
5Y1.8461.313+0.533
10Y1.8511.200+0.651

1.3. Liquidity of Novolog Pharm-Up 1966 Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Novolog is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 0.96 means the company has 0.96 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Novolog Pharm-Up 1966 Ltd:

  • The MRQ is 0.964. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.964. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.964TTM0.9640.000
TTM0.964YOY0.979-0.014
TTM0.9645Y0.987-0.023
5Y0.98710Y0.988-0.001
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9641.374-0.410
TTM0.9641.398-0.434
YOY0.9791.428-0.449
5Y0.9871.401-0.414
10Y0.9881.350-0.362
1.3.2. Quick Ratio

Measures if Novolog is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Novolog to the Medical Distribution industry mean.
  • A Quick Ratio of 0.71 means the company can pay off 0.71 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Novolog Pharm-Up 1966 Ltd:

  • The MRQ is 0.712. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.712. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.712TTM0.7120.000
TTM0.712YOY0.744-0.032
TTM0.7125Y0.737-0.025
5Y0.73710Y0.731+0.005
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7120.738-0.026
TTM0.7120.751-0.039
YOY0.7440.798-0.054
5Y0.7370.791-0.054
10Y0.7310.855-0.124

1.4. Solvency of Novolog Pharm-Up 1966 Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Novolog assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Novolog to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.86 means that Novolog assets are financed with 85.8% credit (debt) and the remaining percentage (100% - 85.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Novolog Pharm-Up 1966 Ltd:

  • The MRQ is 0.858. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.858. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.858TTM0.8580.000
TTM0.858YOY0.810+0.048
TTM0.8585Y0.844+0.013
5Y0.84410Y0.894-0.050
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8580.614+0.244
TTM0.8580.610+0.248
YOY0.8100.600+0.210
5Y0.8440.596+0.248
10Y0.8940.594+0.300
1.4.2. Debt to Equity Ratio

Measures if Novolog is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Novolog to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 644.7% means that company has 6.45 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Novolog Pharm-Up 1966 Ltd:

  • The MRQ is 6.447. The company is unable to pay all its debts with equity. -1
  • The TTM is 6.447. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ6.447TTM6.4470.000
TTM6.447YOY4.524+1.923
TTM6.4475Y5.784+0.664
5Y5.78410Y11.546-5.763
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ6.4471.585+4.862
TTM6.4471.699+4.748
YOY4.5241.693+2.831
5Y5.7841.712+4.072
10Y11.5461.760+9.786

2. Market Valuation of Novolog Pharm-Up 1966 Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Novolog generates.

  • Above 15 is considered overpriced but always compare Novolog to the Medical Distribution industry mean.
  • A PE ratio of -17.28 means the investor is paying -17.28 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Novolog Pharm-Up 1966 Ltd:

  • The EOD is -19.078. Based on the earnings, the company is expensive. -2
  • The MRQ is -17.278. Based on the earnings, the company is expensive. -2
  • The TTM is -17.278. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.078MRQ-17.278-1.800
MRQ-17.278TTM-17.2780.000
TTM-17.278YOY29.595-46.873
TTM-17.2785Y34.475-51.753
5Y34.47510Y23.357+11.118
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD-19.07812.769-31.847
MRQ-17.27813.542-30.820
TTM-17.27815.825-33.103
YOY29.59518.622+10.973
5Y34.47515.030+19.445
10Y23.35722.374+0.983
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Novolog Pharm-Up 1966 Ltd:

  • The EOD is 6.209. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 5.623. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 5.623. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.209MRQ5.623+0.586
MRQ5.623TTM5.6230.000
TTM5.623YOY22.399-16.776
TTM5.6235Y23.150-17.527
5Y23.15010Y2.441+20.709
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD6.2096.474-0.265
MRQ5.6239.109-3.486
TTM5.62312.338-6.715
YOY22.3991.992+20.407
5Y23.1503.149+20.001
10Y2.4414.041-1.600
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Novolog is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 1.83 means the investor is paying 1.83 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Novolog Pharm-Up 1966 Ltd:

  • The EOD is 2.023. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.832. Based on the equity, the company is underpriced. +1
  • The TTM is 1.832. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.023MRQ1.832+0.191
MRQ1.832TTM1.8320.000
TTM1.832YOY3.062-1.230
TTM1.8325Y3.398-1.566
5Y3.39810Y3.231+0.167
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD2.0230.971+1.052
MRQ1.8321.120+0.712
TTM1.8321.134+0.698
YOY3.0621.303+1.759
5Y3.3981.299+2.099
10Y3.2312.025+1.206
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Novolog Pharm-Up 1966 Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---12.908-12.9080%6.230-307%11.533-212%7.756-266%
Book Value Per Share--77.56277.5620%90.470-14%72.363+7%44.859+73%
Current Ratio--0.9640.9640%0.979-1%0.987-2%0.988-2%
Debt To Asset Ratio--0.8580.8580%0.810+6%0.844+2%0.894-4%
Debt To Equity Ratio--6.4476.4470%4.524+43%5.784+11%11.546-44%
Dividend Per Share--3.3093.3090%6.246-47%4.241-22%4.098-19%
Eps---8.224-8.2240%9.360-188%3.850-314%4.346-289%
Free Cash Flow Per Share--25.27025.2700%12.367+104%13.874+82%13.590+86%
Free Cash Flow To Equity Per Share--25.27025.2700%-1.919+108%12.716+99%9.123+177%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--417.878--------
Intrinsic Value_10Y_min--296.608--------
Intrinsic Value_1Y_max--21.618--------
Intrinsic Value_1Y_min--18.053--------
Intrinsic Value_3Y_max--80.390--------
Intrinsic Value_3Y_min--64.669--------
Intrinsic Value_5Y_max--157.776--------
Intrinsic Value_5Y_min--122.358--------
Market Cap80131656710.400+9%72573030073.60072573030073.6000%141468890432.000-49%121744960654.080-40%74896797046.400-3%
Net Profit Margin---0.026-0.0260%0.032-181%0.017-250%0.025-202%
Operating Margin----0%0.052-100%0.040-100%0.045-100%
Operating Ratio--1.8661.8660%1.831+2%1.846+1%1.851+1%
Pb Ratio2.023+9%1.8321.8320%3.062-40%3.398-46%3.231-43%
Pe Ratio-19.078-10%-17.278-17.2780%29.595-158%34.475-150%23.357-174%
Price Per Share156.900+9%142.100142.1000%277.000-49%238.380-40%146.650-3%
Price To Free Cash Flow Ratio6.209+9%5.6235.6230%22.399-75%23.150-76%2.441+130%
Price To Total Gains Ratio-16.345-10%-14.803-14.8030%22.203-167%11.416-230%15.359-196%
Quick Ratio--0.7120.7120%0.744-4%0.737-3%0.731-3%
Return On Assets---0.015-0.0150%0.020-177%0.009-263%0.012-222%
Return On Equity---0.113-0.1130%0.110-203%0.054-309%0.169-167%
Total Gains Per Share---9.599-9.5990%12.476-177%15.774-161%11.854-181%
Usd Book Value--106913057.900106913057.9000%124706485.300-14%99746781.060+7%61834737.760+73%
Usd Book Value Change Per Share---0.035-0.0350%0.017-307%0.031-212%0.021-266%
Usd Book Value Per Share--0.2090.2090%0.244-14%0.195+7%0.121+73%
Usd Dividend Per Share--0.0090.0090%0.017-47%0.011-22%0.011-19%
Usd Eps---0.022-0.0220%0.025-188%0.010-314%0.012-289%
Usd Free Cash Flow--34832754.20034832754.2000%17046344.200+104%19123980.420+82%18732733.380+86%
Usd Free Cash Flow Per Share--0.0680.0680%0.033+104%0.037+82%0.037+86%
Usd Free Cash Flow To Equity Per Share--0.0680.0680%-0.005+108%0.034+99%0.025+177%
Usd Market Cap216275341.461+9%195874608.169195874608.1690%381824535.276-49%328589648.805-40%202146455.228-3%
Usd Price Per Share0.423+9%0.3840.3840%0.748-49%0.643-40%0.396-3%
Usd Profit---11336609.700-11336609.7000%12901759.800-188%5307367.580-314%5953751.090-290%
Usd Revenue--443577681.100443577681.1000%406995435.100+9%353270328.660+26%279267473.280+59%
Usd Total Gains Per Share---0.026-0.0260%0.034-177%0.043-161%0.032-181%
 EOD+4 -4MRQTTM+0 -0YOY+10 -255Y+13 -2210Y+14 -21

3.2. Fundamental Score

Let's check the fundamental score of Novolog Pharm-Up 1966 Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-19.078
Price to Book Ratio (EOD)Between0-12.023
Net Profit Margin (MRQ)Greater than0-0.026
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.712
Current Ratio (MRQ)Greater than10.964
Debt to Asset Ratio (MRQ)Less than10.858
Debt to Equity Ratio (MRQ)Less than16.447
Return on Equity (MRQ)Greater than0.15-0.113
Return on Assets (MRQ)Greater than0.05-0.015
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Novolog Pharm-Up 1966 Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose157.000
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Net Income  1,013,7002,993,0004,006,700225,1004,231,800548,4004,780,200-8,980,500-4,200,300
Net Income from Continuing Operations  1,013,7003,042,3004,056,000426,5004,482,500657,1005,139,600-9,078,200-3,938,600



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in ILS. All numbers in thousands.

Summary
Total Assets2,788,574
Total Liabilities2,392,453
Total Stockholder Equity371,080
 As reported
Total Liabilities 2,392,453
Total Stockholder Equity+ 371,080
Total Assets = 2,788,574

Assets

Total Assets2,788,574
Total Current Assets2,106,422
Long-term Assets682,152
Total Current Assets
Cash And Cash Equivalents 232,939
Net Receivables 1,555,664
Inventory 247,331
Total Current Assets  (as reported)2,106,422
Total Current Assets  (calculated)2,035,934
+/- 70,488
Long-term Assets
Property Plant Equipment 321,403
Goodwill 162,688
Intangible Assets 138,427
Long-term Assets  (as reported)682,152
Long-term Assets  (calculated)622,518
+/- 59,634

Liabilities & Shareholders' Equity

Total Current Liabilities2,184,810
Long-term Liabilities207,643
Total Stockholder Equity371,080
Total Current Liabilities
Short Long Term Debt 913
Accounts payable 1,856,206
Total Current Liabilities  (as reported)2,184,810
Total Current Liabilities  (calculated)1,857,119
+/- 327,691
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt214,195
Long-term Liabilities  (as reported)207,643
Long-term Liabilities  (calculated)214,195
+/- 6,552
Total Stockholder Equity
Total Stockholder Equity (as reported)371,080
Total Stockholder Equity (calculated)0
+/- 371,080
Other
Capital Stock5,107
Net Invested Capital 372,066
Net Working Capital -78,388
Property Plant and Equipment Gross 533,546



Balance Sheet

Currency in ILS. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
1,318,423
1,639,227
1,523,386
1,805,956
1,732,071
2,150,253
2,186,563
2,288,500
2,434,587
2,788,574
2,788,5742,434,5872,288,5002,186,5632,150,2531,732,0711,805,9561,523,3861,639,2271,318,423
   > Total Current Assets 
1,254,076
1,572,268
1,423,296
1,624,369
1,531,889
1,675,459
1,707,968
1,742,121
1,718,609
2,106,422
2,106,4221,718,6091,742,1211,707,9681,675,4591,531,8891,624,3691,423,2961,572,2681,254,076
       Cash And Cash Equivalents 
85,326
204,633
138,875
142,389
107,969
185,108
176,442
238,709
172,806
232,939
232,939172,806238,709176,442185,108107,969142,389138,875204,63385,326
       Short-term Investments 
2,013
3
3
0
0
0
0
0
0
0
0000000332,013
       Net Receivables 
835,440
1,132,519
1,035,374
1,220,541
1,236,156
1,272,215
1,257,164
1,282,845
1,306,388
1,555,664
1,555,6641,306,3881,282,8451,257,1641,272,2151,236,1561,220,5411,035,3741,132,519835,440
       Inventory 
320,557
231,132
245,500
245,246
181,183
214,546
255,642
186,790
189,034
247,331
247,331189,034186,790255,642214,546181,183245,246245,500231,132320,557
       Other Current Assets 
10,740
3
3
12,421
10,228
0
0
0
0
0
0000010,22812,4213310,740
   > Long-term Assets 
0
0
100,090
181,587
200,182
474,794
478,595
546,379
715,978
682,152
682,152715,978546,379478,595474,794200,182181,587100,09000
       Property Plant Equipment 
42,603
41,874
51,587
89,405
100,710
220,130
191,240
224,770
306,623
321,403
321,403306,623224,770191,240220,130100,71089,40551,58741,87442,603
       Goodwill 
15,239
15,239
30,110
61,397
73,970
135,712
144,905
161,060
214,327
162,688
162,688214,327161,060144,905135,71273,97061,39730,11015,23915,239
       Long Term Investments 
0
0
0
0
500
500
0
0
0
0
00005005000000
       Intangible Assets 
18,625
5,860
15,147
27,402
29,097
75,833
75,780
97,400
113,078
138,427
138,427113,07897,40075,78075,83329,09727,40215,1475,86018,625
       Long-term Assets Other 
0
0
100,090
181,587
200,182
474,794
0
0
0
0
0000474,794200,182181,587100,09000
> Total Liabilities 
1,233,521
1,538,958
1,452,706
1,720,244
1,630,457
1,886,476
1,890,892
1,858,269
1,972,540
2,392,453
2,392,4531,972,5401,858,2691,890,8921,886,4761,630,4571,720,2441,452,7061,538,9581,233,521
   > Total Current Liabilities 
1,231,653
1,536,887
1,442,734
1,692,643
1,596,260
1,713,581
1,733,605
1,689,186
1,756,281
2,184,810
2,184,8101,756,2811,689,1861,733,6051,713,5811,596,2601,692,6431,442,7341,536,8871,231,653
       Short-term Debt 
0
0
0
4,885
63
63
0
0
0
0
000063634,885000
       Short Long Term Debt 
0
0
0
4,885
63
63
63
386
1,151
913
9131,1513866363634,885000
       Accounts payable 
1,207,565
1,515,493
1,414,695
1,662,325
1,570,998
1,659,550
1,663,379
1,616,284
1,661,841
1,856,206
1,856,2061,661,8411,616,2841,663,3791,659,5501,570,9981,662,3251,414,6951,515,4931,207,565
       Other Current Liabilities 
24,088
9,728
10,197
5,350
3,908
8,033
20,995
8,895
18,351
0
018,3518,89520,9958,0333,9085,35010,1979,72824,088
   > Long-term Liabilities 
0
0
9,972
27,601
34,197
172,895
157,287
169,083
216,259
207,643
207,643216,259169,083157,287172,89534,19727,6019,97200
       Capital Lease Obligations Min Short Term Debt
0
0
0
-4,885
-63
157,399
153,744
165,509
210,656
214,195
214,195210,656165,509153,744157,399-63-4,885000
> Total Stockholder Equity
84,902
100,269
70,680
85,712
101,614
263,777
294,687
424,370
435,995
371,080
371,080435,995424,370294,687263,777101,61485,71270,680100,26984,902
   Common Stock
1
1
1
3,500
3,500
4,635
4,636
5,066
5,087
0
05,0875,0664,6364,6353,5003,500111
   Retained Earnings 
18,720
33,977
4,598
19,590
39,034
37,580
65,647
75,965
91,867
0
091,86775,96565,64737,58039,03419,5904,59833,97718,720
   Accumulated Other Comprehensive Income 0000000000
   Capital Surplus 0000000000
   Treasury Stock0000000000



Balance Sheet

Currency in ILS. All numbers in thousands.




Cash Flow

Currency in ILS. All numbers in thousands.




Income Statement

Currency in ILS. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,643,489
Cost of Revenue-1,474,323
Gross Profit169,166169,166
 
Operating Income (+$)
Gross Profit169,166
Operating Expense-1,593,071
Operating Income50,418-1,423,905
 
Operating Expense (+$)
Research Development0
Selling General Administrative26,753
Selling And Marketing Expenses0
Operating Expense1,593,07126,753
 
Net Interest Income (+$)
Interest Income12,020
Interest Expense-12,868
Other Finance Cost-0
Net Interest Income-848
 
Pretax Income (+$)
Operating Income50,418
Net Interest Income-848
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,73050,418
EBIT - interestExpense = -12,868
-42,003
-29,135
Interest Expense12,868
Earnings Before Interest and Taxes (EBIT)014,598
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,730
Tax Provision-10,474
Net Income From Continuing Ops-39,386-8,744
Net Income-42,003
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0848
 

Technical Analysis of Novolog
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Novolog. The general trend of Novolog is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Novolog's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Novolog Pharm-Up 1966 Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 163.14 < 164.00 < 167.16.

The bearish price targets are: 144.99 > 144.00 > 140.77.

Tweet this
Novolog Pharm-Up 1966 Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Novolog Pharm-Up 1966 Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Novolog Pharm-Up 1966 Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Novolog Pharm-Up 1966 Ltd.

Novolog Pharm-Up 1966 Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNovolog Pharm-Up 1966 Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Novolog Pharm-Up 1966 Ltd. The current adx is .

Novolog Pharm-Up 1966 Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Novolog Pharm-Up 1966 Ltd.

Novolog Pharm-Up 1966 Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Novolog Pharm-Up 1966 Ltd.

Novolog Pharm-Up 1966 Ltd Daily Relative Strength Index (RSI) ChartNovolog Pharm-Up 1966 Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Novolog Pharm-Up 1966 Ltd.

Novolog Pharm-Up 1966 Ltd Daily Stochastic Oscillator ChartNovolog Pharm-Up 1966 Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Novolog Pharm-Up 1966 Ltd.

Novolog Pharm-Up 1966 Ltd Daily Commodity Channel Index (CCI) ChartNovolog Pharm-Up 1966 Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Novolog Pharm-Up 1966 Ltd.

Novolog Pharm-Up 1966 Ltd Daily Chande Momentum Oscillator (CMO) ChartNovolog Pharm-Up 1966 Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Novolog Pharm-Up 1966 Ltd.

Novolog Pharm-Up 1966 Ltd Daily Williams %R ChartNovolog Pharm-Up 1966 Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Novolog Pharm-Up 1966 Ltd.

Novolog Pharm-Up 1966 Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Novolog Pharm-Up 1966 Ltd.

Novolog Pharm-Up 1966 Ltd Daily Average True Range (ATR) ChartNovolog Pharm-Up 1966 Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Novolog Pharm-Up 1966 Ltd.

Novolog Pharm-Up 1966 Ltd Daily On-Balance Volume (OBV) ChartNovolog Pharm-Up 1966 Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Novolog Pharm-Up 1966 Ltd.

Novolog Pharm-Up 1966 Ltd Daily Money Flow Index (MFI) ChartNovolog Pharm-Up 1966 Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Novolog Pharm-Up 1966 Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-05-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Novolog Pharm-Up 1966 Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Novolog Pharm-Up 1966 Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose157.000
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Novolog with someone you think should read this too:
  • Are you bullish or bearish on Novolog? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Novolog? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Novolog Pharm-Up 1966 Ltd

I send you an email if I find something interesting about Novolog Pharm-Up 1966 Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Novolog Pharm-Up 1966 Ltd.

Receive notifications about Novolog Pharm-Up 1966 Ltd in your mailbox!